. Author manuscript; available in PMC: 2020 Dec 1.

Published in final edited form as: Circ Cardiovasc Imaging. 2019 Dec;12(1):e008176. doi: 10.1161/CIRCIMAGING.118.008176

Table 2:

Comparison of 3D Volumetric and Functional Indices Between Pulmonary Hypertension Patients and Controls

	IPAH	APAH-CHD	Control	P-value
EDVi (mL/m²)	85 (63 – 137)^* ^‡	59 (37 – 99)^*	57 (42 – 82)	< 0.0001
ESVi (mL/m²)	45 (34 – 62)^* ^†	39 (32 – 47)^*	23 (19 – 28)	< 0.0001
SVi (mL/m²)	37 (31 – 44)^*	36 (30 – 40)^*	28 (23 – 35)	< 0.0001
EF (%)	47 (42 – 48)^*	47 (45 – 49)^*	55 (52 – 58)	< 0.0001
SV/ESV	0.87 (0.72 – 0.92)^*	0.89 (0.83 – 0.96)^*	1.21 (1.09 – 1.41)	< 0.0001
FW RVLS (%)	−21 ± 5^*	−22 ± 5^*	−28 ± 4	< 0.0001

Data are reported as mean ± SD or median with corresponding IQR.

P < 0.001 from controls;

^†

P < 0.001,

^‡

P < 0.01 from APAH-CHD. APAH = associated pulmonary artery hypertension. CHD = congenital heart disease, EDVi = end-diastolic volume indexed, EF = ejection fraction, ESVi = end-systolic volume indexed, FW RVLS = free wall right ventricular longitudinal strain, IPAH = idiopathic pulmonary arterial hypertension, SVi = stroke volume indexed.